About CJHP

Focus and Scope

The Canadian Journal of Hospital Pharmacy (CJHP) is the official publication of the Canadian Society of Healthcare-Systems Pharmacy (CSHP). It is published online only (ISSN 1920-2903). The CJHP is a quarterly, peer-reviewed, scientific journal, which publishes original research, brief research reports, reviews, case reports, and topical discussions on pharmacy practice that are of interest and value to health care practitioners in hospitals and related care settings.

Mission: The CJHP is an academic journal that focuses on how pharmacists in hospitals and other collaborative health care settings optimize safe and effective drug use for patients in Canada and throughout the world.

Vision: The aim of the CJHP is to be a respected international publication serving as a major venue for dissemination of information related to patient-centred pharmacy practice in hospitals and other collaborative health care settings in Canada and throughout the world.

Support of the Granada Statements

The CJHP has joined a group of international clinical and social pharmacy journals who adopted the formal title “The International Collaboration of Pharmacy Journal Editors (ICPJE)”. The journal editors first met in Granada, Spain in 2022 to discuss these principles, where they developed the “Granada Statements” including 18 recommendations under six general topic areas. The six topic areas are:

  1. Use of appropriate terminology
  2. Impactful abstracts
  3. Required peer reviews
  4. Journal scattering
  5. Selecting the most appropriate pharmacy practice journal
  6. Using metrics wisely

Full details of these topics and a description of the ICPJE (formerly known as the Granada group of journals) is available on their website: https://granadastatements.weebly.com. The underlying motivation for CJHP joining the ICPJE is to increase awareness and impact of pharmacy practice research, ultimately improving such metrics for the CJHP. The CJHP Editorial Board believes this to be an important initiative for improving the standards of pharmacy practice research and publication for our journal and that it will help advance the profession of pharmacy around the world. 

Publication Frequency and Model

The CJHP publishes four issues per year in March, June, September, and December. Effective January 1, 2024, the CJHP uses a continuous publishing model in which articles are published as soon as they have completed the production process, rather than waiting for all articles in an issue to be completed. This results in quicker access to the final article version and more rapid dissemination of research.

Peer Review Process

All manuscripts are initially reviewed by the Editor, and if appropriate, assigned to an associate editor. If a submission is judged to be suitable for possible publication, the associate editor will send the blinded manuscript to two or more peer reviewers. Once reviewers’ feedback is obtained (they are generally allotted 21 days), the associate editor drafts a decision letter, which is submitted to the Editor for review before being sent to authors.

All articles undergo this process with the following exceptions:

  • Editorial: written by the Editor or an associate editor on a rotating schedule
  • Point Counterpoint: prepared by invitation from the Editorial Board
  • Executive Commentary: written by a member of CSHP’s Executive Committee on a rotating schedule

The CJHP employs a double-blind review process. The identities of authors and reviewers are kept confidential from one another. The manuscript under review is only revealed to editors, reviewers, and editorial staff. Reviewers are required to maintain confidentiality about the manuscripts they review.

During the submission process, Authors are permitted to submit the names of up to three potential reviewers (name, affiliation, and institution/workplace email address), who could, in their opinion, expertly review their manuscript. These reviewers should not have collaborated or published with any of the authors during the past three years and should not currently work or collaborate with any of the authors. Authors may also request to exclude a maximum of two individual reviewers from consideration. The Editors, however, reserve the right to choose all reviewers and their choice is final.

The timeline from submission to initial Editor decision can take 2 to 4 months. The timeline from submission to the final Editor decision may take anywhere from 3 to 12 months, depending on how many revisions the manuscript must undergo.

Indexing

CJHP is covered by the following major indexes, aggregators, and services:

  • PubMed
  • PubMed Central (PMC)
  • Web of Science, Emerging Sources Citation Index (ESCI)
  • EBSCO Discovery Service (including IPA)
  • Scopus
  • Embase
  • Crossref
  • Google Scholar

Delayed Open Access

The contents of this Journal will be available in a free to read format 6 months after an issue is published.

While CJHP’s Editorial, Point Counterpoint, Commentary from the Presidential Team, and Chief Executive Officer’s Report are immediately accessible upon publication, all other articles are embargoed for the duration of 6 months. A pay-per-view system has been introduced for embargoed articles.

Authors who wish to have their articles immediately accessible upon publication can do so by paying a $100 fee to forgo the embargo period. Simply complete the CJHP’s Authorship Fee Form and send it to publications@cshp.ca.

Article Purchase

Readers without a subscription may purchase individual articles for their personal use.

Fee to purchase an article: $30.00 (CAD)

The payment of this fee will enable you to view, download, and print the article.

Please contact the CSHP with your request.

Disclaimer

The CSHP assumes no responsibility for the statements and opinions advanced by contributors to the CJHP. Views expressed in the editorials are those of the authors and do not necessarily represent the official position of CSHP.